• Home
  • Search
  • Site Map
  • 繁體中文
  • English
MegaPro Bio 巨生生醫
Open menu
  • About MegaPro
    • Company History
    • Future vision
    • Organizational Structure
    • Team Introduction
    • Recruitment
  • Newsroom
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Product and Technology Platform
    • Products
      • Current Progress of Product Development
      • MPB-1514
      • MPB-1523 (IOP Injection)
      • MPB-1734: A New Formulation Anti-cancer Drug
    • Technology Platform
      • Nanoparticle Technology Platform
      • Nanocell Technology Platform
      • Clinical Trial Platform for Nano Medicines
  • 2025

Site Map

  • About MegaPro
    • Company History
    • Future vision
    • Organizational Structure
    • Team Introduction
    • Recruitment
  • Newsroom
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Product and Technology Platform
    • Products
      • Current Progress of Product Development
      • MPB-1514
      • MPB-1523 (IOP Injection)
      • MPB-1734: A New Formulation Anti-cancer Drug
    • Technology Platform
      • Nanoparticle Technology Platform
        • PEGylation technology platform
        • Nano Iron Oxide Drug
        • Cell and Molecular Imaging Technology Platform - MRI imaging technology
        • Immune Cell Targeting Technology Platform - image of immune cells
      • Nanocell Technology Platform
        • Nanomedicine technology platform
        • Nano-grafting Technology Platform
        • Nano-encapsulation technology platform
      • Clinical Trial Platform for Nano Medicines
  • 2025
  • About MegaPro
    • Company History
    • Future vision
    • Organizational Structure
    • Team Introduction
    • Recruitment
  • Newsroom
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Product and Technology Platform
    • Products
    • Technology Platform
  • 2025

30261 新竹縣竹北市生醫五路66號10樓之1  竹北生醫園區 第二生技大樓 ©巨生生醫股份有限公司
10F-1, No. 66, Shengyi 5th RD. Zhubei City, Hsinchu 302, Taiwan, R.O.C.
Tel: +866-3-591-0360 Fax:+886-3-591-0441
©MegaPro Biomedical Co., Ltd. Copyright ｜ Contact us  |  登入

megaprobio QR

DR Anywhere
  • About MegaPro
    • Company History
    • Future vision
    • Organizational Structure
    • Team Introduction
    • Recruitment
  • Newsroom
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Product and Technology Platform
    • Products
      • Current Progress of Product Development
      • MPB-1514
      • MPB-1523 (IOP Injection)
      • MPB-1734: A New Formulation Anti-cancer Drug
    • Technology Platform
      • Nanoparticle Technology Platform
        • PEGylation technology platform
        • Nano Iron Oxide Drug
        • Cell and Molecular Imaging Technology Platform - MRI imaging technology
        • Immune Cell Targeting Technology Platform - image of immune cells
      • Nanocell Technology Platform
        • Nanomedicine technology platform
        • Nano-grafting Technology Platform
        • Nano-encapsulation technology platform
      • Clinical Trial Platform for Nano Medicines
  • 2025